a.ferreira
Submits third-party assay reports on material purchased directly. Based in Cali.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
5
n=5
Annotations
0
n=0
Median purity submitted
99.03%
n=5
Suppliers covered
5
n=5
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043184 | PT-141 (Bremelanotide) | GL Biochem | GLBI-2511-F8417 | VendorInvestigate | 2026-Q2 | 97.67 | 3.01 | 99.8 | Buyer-sourced | 2 | FAIL |
| AX-2025-020054 | Oxytocin | ERP | ERP-2503-A7432 | Janoshik | 2025-Q2 | 98.72 | 4.96 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019282 | Dihexa | TFC | TFC-2409-U6527 | Janoshik | 2025-Q1 | 99.21 | 6.37 | 102.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018536 | MK-677 (Ibutamoren mesylate) | WWB | WWB-2411-X3830 | Medutest | 2025-Q1 | 99.61 | 2.79 | — | Supplier-supplied | 1 | FAIL |
| AX-2024-005097 | Pramlintide | MKM | MKM-2405-U4415 | Janoshik | 2024-Q3 | 99.03 | 4.15 | 98.4 | Supplier-supplied | 0 | PASS |
| Supplier | Records | Median purity |
|---|---|---|
| GL Biochem | 1 | n<3 |
| ERP | 1 | n<3 |
| TFC | 1 | n<3 |
| WWB | 1 | n<3 |
| MKM | 1 | n<3 |